Neutralization of MERS coronavirus through a scalable nanoparticle vaccine

MERS-CoV continues to cause human outbreaks, so far in 27 countries worldwide following the first registered epidemic in Saudi Arabia in 2012. In this study, we produced a nanovaccine based on virus-like particles (VLPs). VLPs are safe vaccine platforms as they lack any replication-competent genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohsen, Mona O., Rothen, Dominik, Balke, Ina, Martina, Byron, Zeltina, Vilija, Inchakalody, Varghese, Gharailoo, Zahra, Nasrallah, Gheyath, Dermime, Said, Tars, Kaspars, Vogel, Monique, Zeltins, Andris, Bachmann, Martin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384877/
https://www.ncbi.nlm.nih.gov/pubmed/34429427
http://dx.doi.org/10.1038/s41541-021-00365-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384877/
https://www.ncbi.nlm.nih.gov/pubmed/34429427
http://dx.doi.org/10.1038/s41541-021-00365-w

Ejemplares similares